Marion Dorsch
Presidente presso Atavistik Bio, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Kaye Foster-Cheek | F | 64 | 10 anni | |
| May Kin Ho | M | 71 | 9 anni | |
| Bryan Stuart | M | 47 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | 1 anni |
| Christina Rossi | F | 48 | 6 anni | |
| Becker Hewes | M | 58 | 4 anni | |
| Jim Burns | M | 46 | 8 anni | |
| Helen Hobbs | M | 71 |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | - |
| John Josey | M | 63 |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | 2 anni |
| Fouad Namouni | M | 55 | 4 anni | |
| Adam Goulburn | M | 42 |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | - |
| Christopher Murray | M | 61 | 7 anni | |
| Lauren Barnes | F | 50 | 5 anni | |
| Janet Loesberg | M | 61 | 4 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Kevin Starr | M | 61 | 7 anni | |
| Eric Schweitzer | M | 59 |
Freie Universität Berlin
| 6 anni |
| Marc Tessier-Lavigne | M | 64 | 5 anni | |
| Perry Karsen | M | 69 | 5 anni | |
| Paul Clancy | M | 62 | 10 anni | |
| Megan E. Pace | F | 51 | - | |
| Darrin Miles | M | - | 6 anni | |
| Hans-Georg Frank | M | 63 |
Freie Universität Berlin
| 7 anni |
| Glenn Goddard | M | 53 | 6 anni | |
| J. Goater | M | 48 |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | 2 anni |
| Frank Czichowski | M | 64 |
Freie Universität Berlin
| 10 anni |
| Jacqueline Cinicola | F | - | 7 anni | |
| Sacha Fabian Berlik | M | 54 |
Freie Universität Berlin
| 5 anni |
| Camille Henderson | M | - | 4 anni | |
| Kristian Schmidt-Garve | M | 53 |
Freie Universität Berlin
| 5 anni |
| Quaza Nizamuddin bin A. Hassan Nizam | M | 64 |
Freie Universität Berlin
| 1 anni |
| Robert Sheroff | M | 69 | 2 anni | |
| Nikolas von Haugwitz | M | 56 |
Freie Universität Berlin
| 4 anni |
| Melissa McLaughlin | F | - | 7 anni | |
| Renee T. Leck | F | - | 3 anni | |
| Ann J. Barbier | M | 59 | 2 anni | |
| Petra Wierzchowski | F | 58 |
Freie Universität Berlin
| 4 anni |
| Caroline Knöri | F | 49 |
Freie Universität Berlin
| 4 anni |
| Richa Poddar | F | - | 6 anni | |
| Kevin Marks | M | - | 2 anni | |
| Eyal Attar | M | 53 | 5 anni | |
| Hanns-Alexander Klemm | M | - |
Freie Universität Berlin
| 3 anni |
| Constanze Ulmer-Eilfort | M | 62 |
Freie Universität Berlin
| 3 anni |
| Dorte Hoppner | M | - |
Freie Universität Berlin
| 4 anni |
| Christopher Turner | M | 56 | 3 anni | |
| Robert J. DeVita | M | - | - | |
| Christine Wolff | F | 63 |
Freie Universität Berlin
| 1 anni |
| Niko Stumpfögger | M | 68 |
Freie Universität Berlin
| 2 anni |
| Martin Kleinschmitt | M | 64 |
Freie Universität Berlin
| 3 anni |
| Bernd Buchholz | M | 62 |
Freie Universität Berlin
| 4 anni |
| Henrik Colell | M | 61 |
Freie Universität Berlin
| 4 anni |
| Marion Helmes | M | 58 |
Freie Universität Berlin
| 4 anni |
| John Duncan Higgons | M | 69 | 7 anni | |
| Frank Conarad | M | 62 |
Freie Universität Berlin
| 4 anni |
| Torsten Leue | M | 58 |
Freie Universität Berlin
| 4 anni |
| Arndt Rolfs | M | 64 |
Freie Universität Berlin
| 4 anni |
| Pamela Knapp | F | 66 |
Freie Universität Berlin
| 4 anni |
| Christopher Bowden | M | 63 | 7 anni | |
| Alojzy Zbigniew Nowak | M | - |
Freie Universität Berlin
| 4 anni |
| Stefan Herm | M | - |
Freie Universität Berlin
| 5 anni |
| Andrew Hirsch | M | 53 | 4 anni | |
| Martin Auer | M | 64 |
Freie Universität Berlin
| 3 anni |
| Matthias Lindenberger | M | 57 |
Freie Universität Berlin
| - |
| Christoph S. Lengauer | M | 59 | 4 anni | |
| Jörg Lübcke | M | 58 |
Freie Universität Berlin
| 4 anni |
| Karl-Ludwig Soll | M | - |
Freie Universität Berlin
| 4 anni |
| Meredith Goldwasser | M | 52 | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 37 | 56.92% |
| Germania | 28 | 43.08% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Marion Dorsch
- Contatti personali
